Physician profile
Steven C Murphy
NPI 1144674185
$18,106.69
in general payments reported to CMS, 2019-2025
17 companies · $2,569 in 2025
The $2,569 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.99 · 2020: $19.03 · 2021: $24.04 · 2022: $11K · 2023: $1,209 · 2024: $2,821 · 2025: $2,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,575 · Travel and Lodging: $2,919 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,574.53 |
| Travel and Lodging | $2,918.63 |
| Education | $105.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,538.99 | 2022-2025 | |
| Legacy Ortho LLC | $3,986.94 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $2,401.85 | 2022-2025 | Persona, Arcos, G7 |
| Stryker Corporation | $2,108.85 | 2022-2025 | Mako, Gamma, Axsos |
| Cdc Medical LLC | $252.86 | 2024 | |
| Depuy Synthes Sales INC. | $235.33 | 2023-2025 | Va-Lcp, Na, Lcp |
| Cerapedics INC. | $105.60 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Medline Industries LP | $102.38 | 2024 | |
| Kci USA, INC. | $73.13 | 2022 | |
| Mallinckrodt Enterprises LLC | $66.99 | 2019 | |
| Smith+Nephew, INC. | $46.41 | 2025 | N/A, Kvac, Spatial Frame |
| Vericel Corporation | $45.30 | 2022-2024 | Maci |
| Avanos Medical | $43.07 | 2020-2021 | |
| Curonix LLC | $30.68 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ferring Pharmaceuticals INC. | $26.11 | 2023 | Euflexxa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.63 | 2024 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $19.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.